BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16175935)

  • 1. A case with epilepsy, cognitive impairment, renal microangiopathy and high titres of anticentromere and anticardiolipin antibodies.
    Serelis J; Tektonidou MG; Skopouli FN
    Lupus; 2005; 14(8):625-8. PubMed ID: 16175935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients.
    Formiga F; Mitjavila F; Pac M; Moga I
    Lupus; 1997; 6(5):486. PubMed ID: 9229372
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nailfold capillary microscopy in patients with anticardiolipin antibodies: a case-control study.
    Vayssairat M; Abuaf N; Deschamps A; Baudot N; Gaitz JP; Chakkour K; Nussaume O
    Dermatology; 1997; 194(1):36-40. PubMed ID: 9031789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome and the kidneys.
    Uthman I; Khamashta M
    Semin Arthritis Rheum; 2006 Jun; 35(6):360-7. PubMed ID: 16765713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livedo reticularis in a patient with systemic lupus erythematosus and anticardiolipin antibodies.
    Genovese A; Spadaro G; Marone G
    Clin Exp Dermatol; 1993 Mar; 18(2):159-61. PubMed ID: 8481995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Livedo reticularis in patients with systemic lupus erythematosis and its association with anticardiolipin antibodies].
    Ostos Z; Chacón-Petrola Mde L; Flores-Ch ME; Torres A; Herrera A; Blanck E; Espig H
    Invest Clin; 2002 Mar; 43(1):15-24. PubMed ID: 11921743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.
    Raghavan C; Ditchfield J; Taylor RJ; Haeney MR; Barnes PC
    J Clin Pathol; 1993 Dec; 46(12):1113-5. PubMed ID: 8282835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal artery stenosis: a new facet of the antiphospholipid (Hughes) syndrome.
    Sangle SR; D'Cruz DP
    Lupus; 2003; 12(11):803-4. PubMed ID: 14667094
    [No Abstract]   [Full Text] [Related]  

  • 11. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. A case report and review of the literature.
    Kniaz D; Eisenberg GM; Elrad H; Johnson CA; Valaitis J; Bregman H
    Am J Nephrol; 1992; 12(1-2):126-33. PubMed ID: 1492877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
    Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
    Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: a case report.
    Jeruc J; Popovic M; Vizjak A; Jurcić V; Lestan B; Ferluga D
    Folia Neuropathol; 2006; 44(2):140-3. PubMed ID: 16823697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedo reticularis: a rare manifestation of Graves hyperthyroidism associated with anticardiolipin antibodies.
    Liel Y
    South Med J; 2004 Jun; 97(6):601-3. PubMed ID: 15255431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy.
    Reitblat T; Polishchuk I; Dorodnikov E; Aladjem Z; Turiansky L; Zamir D; Kahana E
    Lupus; 2003; 12(1):67-9. PubMed ID: 12587830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Sapporo criteria for antiphospholipid syndrome.
    Lockshin MD; Sammaritano LR; Schwartzman S
    Arthritis Rheum; 2000 Feb; 43(2):440-3. PubMed ID: 10693886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.